{"id":120694,"date":"2020-03-23T13:40:40","date_gmt":"2020-03-23T12:40:40","guid":{"rendered":"http:\/\/polishscience.pl\/?p=120694"},"modified":"2020-03-23T13:40:40","modified_gmt":"2020-03-23T12:40:40","slug":"biotech-company-biotts-working-on-the-development-of-antidiabetic-therapies","status":"publish","type":"post","link":"https:\/\/www.polishscience.pl\/en\/biotech-company-biotts-working-on-the-development-of-antidiabetic-therapies\/","title":{"rendered":"Biotech company Biotts working on the development of antidiabetic therapies"},"content":{"rendered":"<p><strong>The Wroc\u0142aw company Biotts received PLN 11.2 million under the initiative &#8220;Fast Track&#8221; of the National Center for Research and Development. The money is intended to help start work on the development of antidiabetic therapies.<\/strong><\/p>\n<p>In the project, co-financed by the National Center for Research and Development, we will develop a new drug applied to the skin, containing an innovative carrier, thanks to which we will transport anti-diabetic substances through the skin (into the bloodstream). This is a real breakthrough, expected for years by patients suffering from diabetes and pharmaceutical companies &#8211; says Konrad Krajewski, managing partner of Biotts.<\/p>\n<p>The solutions of the Wroclaw company will allow the transport of drugs through the skin. Until now, such a solution for most pharmaceuticals was impossible. This can apply to commonly used oncological, anti-inflammatory or analgesic drugs. The technology will reduce the cost of treatment and replace oral forms of drug delivery, burdening the digestive system or painful injections.<br \/>\nMore: <a href=\"http:\/\/polishscience.pl\/wp-admin\/_wp_link_placeholder\">https:\/\/www.wroclaw.pl\/business\/biotts-rozwoj-terapii-p Anticukrzycowych-transport-lekow-przez-skore?fbclid=IwAR2yRIcr4zVT5dskK4jy6r6ZWJNF35mGiTlRmelhRRqKqXXZPK8<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Wroc\u0142aw company Biotts received PLN 11.2 million under the initiative &#8220;Fast Track&#8221; of the National Center for Research and Development. The money is intended to help start work on the development of antidiabetic therapies. In the project, co-financed by the National Center for Research and Development, we will develop a new drug applied to [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[27],"tags":[],"_links":{"self":[{"href":"https:\/\/www.polishscience.pl\/en\/wp-json\/wp\/v2\/posts\/120694"}],"collection":[{"href":"https:\/\/www.polishscience.pl\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.polishscience.pl\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.polishscience.pl\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.polishscience.pl\/en\/wp-json\/wp\/v2\/comments?post=120694"}],"version-history":[{"count":0,"href":"https:\/\/www.polishscience.pl\/en\/wp-json\/wp\/v2\/posts\/120694\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.polishscience.pl\/en\/wp-json\/wp\/v2\/media?parent=120694"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.polishscience.pl\/en\/wp-json\/wp\/v2\/categories?post=120694"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.polishscience.pl\/en\/wp-json\/wp\/v2\/tags?post=120694"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}